Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
7 offices
Technology Company

We have observed 164 EP applications Deeba Hussain has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11825713

NOVEL THIAZOL-CARBOXIMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A61K 31/425, C07D 277/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11836931

NOVEL HETEROARYL-CARBOXAMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A61K 31/425, A61K 31/445, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11836930

NOVEL THIAZOLE-CARBOXAMIDE DERIVATIVES AS PDK1 INHIBITORS

IPC classification:
A61K 31/445, A61K 31/425, A01N 43/40
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11825711

CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA AAA COUPLING

IPC classification:
C07H 21/04, C07H 21/02, C12P 19/34
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12777344

AMIDATION PROCESS

IPC classification:
C07C 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12709453

PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES

IPC classification:
A61K 31/445, C07D 405/12, C07D 403/10, C07D 403/04, C07D 401/14, C07D 401/10, C07D 401/06, C07D 401/04, C07D 309/12, C07D 223/08, C07D 211/96, C07D 211/46, C07D 207/48, C07D 207/273, C07D 207/12
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779616

DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES

IPC classification:
A61K 31/15, A01N 33/24, C07C 243/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP12776497

HETEROCYCLIC COMPOUNDS AS B-RAF INHIBITORS FOR TREATMENT OF CANCER

IPC classification:
A61K 31/195, A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP11825728

FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS

IPC classification:
C07D 405/14, C07D 401/04, C07D 417/14, C07D 401/14, C07D 471/04, A61K 31/40, A01N 43/38
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12789446

ARYLOXYMETHYL CYCLOPROPANE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11836946

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)

IPC classification:
C07H 21/02, C12N 15/11
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Status:
The patent has been granted
EP12825316

BENZOPIPERAZINE DERIVATIVES AS CETP INHIBITORS

IPC classification:
C07D 498/00, C07D 487/00, C07D 243/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12826237

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP11831236

FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04, C07D 495/14, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
The patent has been granted
EP12743963

KISSPEPTIDE-PENTASACCHARIDE CONJUGATES

IPC classification:
A61K 47/48, A61P 15/08
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12832050

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP11836944

DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES

IPC classification:
A61P 9/12, C07D 307/20, C07D 207/273, C07D 207/16, C07D 207/12, C07D 417/04, C07D 413/10, C07D 413/04, C07D 403/10, C07D 403/04, C07D 401/12, C07D 401/04, C07D 309/12, A61K 31/655
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
The patent has been granted
EP12746994

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61P 19/10, A61P 19/00, A61P 3/10, C07C 317/32, A61K 31/165
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12834135

PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12833774

TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12833256

IMIDAZOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12796872

RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION

IPC classification:
A61K 31/7088, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
EXAMINATION IN PROGRESS
EP12762254

FSH RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/506, A61K 31/4745, A61K 31/444, A61K 31/4375, A61K 31/437, C07D 471/14, C07D 471/04, A61P 15/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12838891

TRIAZOLYL PDE10 INHIBITORS

IPC classification:
A01N 43/38
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12839780

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12840391

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12839466

PHARMACEUTICAL COMPOSITIONS THAT INHIBIT DISPROPORTIONATION

IPC classification:
A01N 25/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12839960

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12844384

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/4965, C07D 241/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12843432

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/4412
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12844606

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/4965, C07D 241/08
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12844023

SUBSTITUTED PIPERIDINYL COMPOUNDS USEFUL AS GPR119 AGONISTS

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12781551

FUSED BICYCLIC OXAZOLIDINONE CETP INHIBITOR

IPC classification:
A61K 31/4188, C07D 498/04, A61P 9/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12843484

PARI-MUTUEL PREDICTION MARKETS AND THEIR USES

IPC classification:
G06Q 40/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12845954

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 29/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12846651

PROCESS FOR A CETP INHIBITOR

IPC classification:
A01N 43/76
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12845426

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12849788

SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14174698

Composition for inhibition of cathepsin K

IPC classification:
A61K 45/06, A61K 31/66, A61K 31/592, A61K 31/44, A61K 31/427, A61K 31/415, A61K 31/275, A61K 9/48, A61K 9/20, A61K 9/08, A61P 19/10
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12770627

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/44, A61K 31/416, C07D 413/06, C07D 401/04, C07D 231/56, A61P 9/00, A61P 3/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12857488

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP14176452

Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors

IPC classification:
A61K 31/4439, C07D 401/10, A61P 35/00, A61P 29/00
Applicant:
MSD Italia S.r.l.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14173412

Heterocyclic compounds as factor IXA inhibitors.

IPC classification:
A61K 31/416, A61K 31/4155, A61K 31/4152, A61K 31/415, C07D 487/04, C07D 413/14, C07D 413/04, C07D 403/14, C07D 403/04, C07D 401/14, C07D 401/04, C07D 231/18, A61P 7/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12804259

PROCESS FOR PREPARING CHIRAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/513, A61K 31/4985, A61K 31/4439
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12776492

ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A61K 45/06, A61K 31/41, A01N 43/64, C07D 519/00, C07D 487/04, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12800644

PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS WITH SIMVASTATIN

IPC classification:
A61K 9/28, A61K 9/16
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12817088

FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS

IPC classification:
A61K 31/519, A01N 43/90, C07D 519/00, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13749397

DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

IPC classification:
A61K 31/4162, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12736795

MINERALOCORTICOID RECEPTOR ANTAGONISTS

IPC classification:
A61P 13/12, A61P 9/12, A61P 9/06, A61P 9/04, A61P 3/00, A61K 31/416, A61K 31/404, C07D 413/06, C07D 405/06, C07D 403/06, C07D 403/04, C07D 231/56, C07D 209/10, C07D 209/08
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13757283

PREPARATION AND USE OF BICYCLIC HIMBACINE DERIVATIVES AS PAR-RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13767554

ASYMMETRIC SYNTHESIS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS

IPC classification:
C07C 229/02, C07C 17/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13769309

PROCESS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS

IPC classification:
C07C 229/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769291

PREDICTIVE BIOMARKER USEFUL FOR CANCER THERAPY MEDIATED BY A CDK INHIBITOR

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769216

THROMBIN INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12844405

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12836652

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

IPC classification:
A61K 31/445, C07D 401/08, A61P 3/10, A61P 3/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP13784511

CYCLIC AMINE SUBSTITUTED HETEROCYCLIC CETP INHIBITORS

IPC classification:
A61K 31/443
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12762256

FSH RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/5377, A61K 31/4439, A61K 31/4155, A61K 31/404, C07D 493/04, C07D 409/14, C07D 409/12, C07D 405/14, C07D 405/12, C07D 401/12, C07D 209/14, A61P 15/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13772609

ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A61K 31/41, A01N 43/64
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP13816893

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2493 PROTEIN

IPC classification:
A61K 39/085, A61K 39/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13822862

TREATING DIABETES WITH DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/4162, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13823622

TREATING DIABETES WITH DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/4439, C07D 487/14, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13745315

SPIRO - FUSED PIPERIDINE DERIVATIVES FOR USE AS INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/438, C07D 519/00, C07D 471/20, C07D 471/10, A61P 9/12
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13750427

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61K 31/435, C07F 9/40, C07D 401/14, C07D 401/12, C07D 221/16, A61P 3/10, A61P 3/06, A61P 3/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13831336

NOVEL AZABENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES

IPC classification:
A61K 31/454, A61K 31/4184, A61K 31/415, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830916

NOVEL BENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES

IPC classification:
A61K 31/4184, A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830944

NOVEL BENZIMIDAZOLE TETRAHYDROFURAN DERIVATIVES

IPC classification:
A61K 31/454, A61K 31/4184, A61K 31/415, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830714

NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES

IPC classification:
A61K 31/454, A61K 31/4184, A61K 31/415, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13830277

NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES

IPC classification:
A61K 31/454, A61K 31/4184, A61K 31/415, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13841430

TRIAZOLYL DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/506, C07D 417/14, C07D 417/12, C07D 239/50, A61P 35/00, A61P 29/00, A61P 11/06
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Merck Canada Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13843259

INDOLINE COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITIORS RELATED APPLICATIONS

IPC classification:
A61K 31/4439, A61K 31/4164
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13831487

NOVEL BENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES

IPC classification:
A61K 31/4184, A01N 43/50
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13853278

PRODRUG BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13852548

AMINO-PYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

IPC classification:
A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855335

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

IPC classification:
A61K 31/522, A61K 31/52, C07D 473/38, C07D 473/30, C07D 473/00, A61P 37/00, A61P 35/00, A61P 19/02, A61P 11/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855780

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

IPC classification:
A61K 31/52, C07D 473/34, A61P 37/00, A61P 35/00, A61P 19/02, A61P 11/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13857464

THROMBIN INHIBITORS

IPC classification:
A61K 31/401, A61K 31/165, A61P 7/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13843517

SUBSTITUTED ISOQUINOLINES AS CRTH2 RECEPTOR MODULATORS

IPC classification:
A61K 31/47, A61K 31/4245, A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13859070

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13860451

CONDITIONAL REPLICATING VIRAL VECTORS

IPC classification:
C12N 15/86
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13861998

AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61K 31/55, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13864999

NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07F 9/32
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13873301

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865060

INDAZOLE COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS

IPC classification:
A61K 31/415, A01N 43/46, C07D 401/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13865518

THERAPEUTIC THIAZOLIDINONE COMPOUNDS

IPC classification:
A61K 31/426, C07D 277/14, A61P 9/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864370

THIAZOLE-SUBSTITUTED AMINOPYRIDINES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/44, A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13863880

FACTOR IXa INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13866418

FACTOR IXA INHIBITORS

IPC classification:
A61K 31/5377, C07D 413/12
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865292

SPIROCYCLIC CETP INHIBITORS

IPC classification:
A61K 31/421, C07D 263/02, A61P 9/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11829806

LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY

IPC classification:
C12N 15/88, C07C 217/08, A61K 9/14, A61K 9/51
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14757359

IMMOBILIZED TRANSAMINASES AND PROCESS FOR MAKING AND USING IMMOBILIZED TRANSAMINASE

IPC classification:
C12N 11/08, C12N 9/96, C12N 9/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14754282

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/357
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11841433

POLY(AMIDE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES

IPC classification:
C08G 69/10, A61K 31/7088
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14770645

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 471/10, A61K 31/438
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14769986

IMMOBILIZED KETOREDUCTASES AND PROCESS FOR MAKING AND USING IMMOBILIZED KETOREDUCTASE

IPC classification:
C12N 9/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14768236

PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/40
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14763846

NOVEL INDOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

IPC classification:
A61P 3/10, A61K 31/5365, A61K 31/41, A61K 31/495, A61K 31/4353, A61K 31/404, C07D 487/04, C07D 471/04, C07D 403/10, C07D 209/30, C07D 209/12
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14767371

CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 37/00, A61P 35/00, A61P 25/00, A61K 31/4375, A61K 31/437, C07D 487/14, C07D 487/08, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770170

GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 19/02, A61P 29/00, A61P 37/00, A61K 31/444, A61K 31/437, C07D 205/04, C07D 211/00, C07D 309/02, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770056

ACYCLIC CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 37/00, A61P 35/00, A61P 25/00, A61K 31/4375, A61K 31/437, C07D 487/14, C07D 487/08, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14767458

N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14773353

METHODS FOR PREPARING SGLT2 INHIBITORS

IPC classification:
A61K 31/70
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15182403

PROCESS FOR SYNTHESIZING A CETP INHIBITOR

IPC classification:
C07D 263/22, A61K 31/421
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14788786

THIAZOLE-SUBSTITUTED AMINOPYRIMIDINES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
C07D 417/14, A61P 29/00, A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14788026

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/426, A61K 31/53, A61K 31/44
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11836910

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 401/04, C07D 213/72, C07D 401/14, A61P 9/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11849978

INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS

IPC classification:
C07D 417/04, C07D 403/14, C07D 401/14, C07D 471/04, C07D 401/04, A61P 35/00, C07D 231/56, A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11836912

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A61K 31/496
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14856821

GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE

IPC classification:
C07D 209/18, A61P 3/10, A61K 31/404
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11836899

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 309/30, C07D 307/88, C07D 295/155, C07D 295/15, C07D 295/13, C07D 271/12, C07D 213/61
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11836937

CYCLIC AMINE SUBSTITUTED OXAZOLIDINONES AS CETP INHIBITORS

IPC classification:
A61P 3/06, A61P 9/10, A61K 31/4427, A61K 31/506, A61K 31/422, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
PATENT GRANTED
EP14870931

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

IPC classification:
C07D 307/91, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15759159

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5377
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15760695

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

IPC classification:
C07D 241/36, C07D 281/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15715934

4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61P 1/16, A61K 31/7076, A61K 31/7064, C07H 19/14, C07H 19/06, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15774282

PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/513, A61K 31/506, A61K 31/501
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15780578

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15779184

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15783339

FACTOR XIa INHIBITORS

IPC classification:
C07D 498/20, A61K 31/438, C07D 471/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15800524

FACTOR XIA INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4192, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15821775

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15821391

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829495

[5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS

IPC classification:
C07D 307/79, A61K 31/443, A61K 31/343
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15827597

FACTOR XIa INHIBITORS

IPC classification:
A61P 7/02, A61K 31/4184, C07D 401/06
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15826790

FACTOR XIa INHIBITORS

IPC classification:
A61P 7/02, A61K 31/433, A61K 31/422, A61K 31/4192, A61K 31/4164, C07D 271/10, C07D 285/04, C07D 249/06, C07D 263/30, C07D 257/06, C07D 233/54
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15827513

FACTOR XIa INHIBITORS

IPC classification:
A61P 7/02, C07D 401/10, C07D 401/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15756648

METHODS OF TREATING ACUTE MYELOID LEUKEMIA OR ACUTE LYMPHOID LEUKEMIA USING PHARMACEUTICAL COMPOSITIONS CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/02, A61K 9/20, A61K 47/26, A61K 31/551
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15837715

TETRAHYDROISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
C07D 217/06, A61P 9/10, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15838154

ISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
C07D 217/12, A61P 9/10, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15838912

TETRAHYDROISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2

IPC classification:
C07D 217/06, A61P 9/10, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15850726

PREPARATION AND USE OF CYCLIC SULFONAMIDE DERIVATIVES AS PAR-1 RECEPTOR ANTAGONISTS

IPC classification:
C07D 277/62, A61K 33/16, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15849961

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 211/62, C07D 211/28
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15853228

NARGENICIN COMPOUNDS AND USES THEREOF AS ANTIBACTERIAL AGENTS

IPC classification:
C07D 493/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15855693

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 211/62, C07D 211/28
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15854736

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 211/62, C07D 211/28
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15854604

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 211/62, C07D 211/28
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15854663

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 211/62, C07D 211/28
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15859787

SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE

IPC classification:
C07H 15/203, C07H 7/04, A61K 31/7048, A61K 31/7034
Applicant:
Pfizer Inc
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15864954

FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT

IPC classification:
A61K 9/10, A61P 27/06, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15865871

PROCESS FOR THE PREPARATION OF TERT-BUTYL 4-((2S,5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDO)PIPERIDINE-1-CARBOXYLATE AND ANALOGS THEREOF

IPC classification:
C07F 7/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15866965

FACTOR IXA INHIBITORS

IPC classification:
C07D 235/04, A61K 31/4184
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15867817

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/522, A61K 31/7072, C07D 471/04, A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15868594

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15870772

(S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3- (METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS

IPC classification:
C07D 401/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15870726

ERK INHIBITORS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15870725

ERK INHIBITORS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP15870773

(S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3-(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS

IPC classification:
C07D 403/04, A61K 31/435, A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP17173914

NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

IPC classification:
A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16740526

FACTOR XIA INHIBITORS

IPC classification:
C07D 471/00, A61K 31/4375
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16743895

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 471/10, A61P 9/12, A61K 31/438
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16749643

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
A01N 57/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16752841

FACTOR IXa INHIBITORS

IPC classification:
A61K 31/4184, A61K 31/4164, A61K 31/395, A61K 31/41, A61K 31/33
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16769334

CONTAINMENT AND TRANSFER DEVICE FOR HIGHLY ACTIVE OR SENSITIVE COMPOUNDS

IPC classification:
F16B 7/04, F16B 2/10, F16B 2/02, B65D 81/32, A61M 39/28, A61M 39/20, A61M 39/18, A61M 39/16, A61M 39/12, A61M 39/10
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16769646

COMPOSITION AND METHODS FOR TREATING CHRONIC KIDNEY DISEASE

IPC classification:
A61K 31/535
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16712876

VAGINAL RING APPLICATOR

IPC classification:
A61F 13/28, A61M 31/00, A61F 6/12, A61F 6/08, A61K 9/00, A61F 13/26
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16780505

FACTOR XIa INHIBITORS

IPC classification:
C07D 241/00, A61P 9/00, A61K 31/4178, A61K 31/426, C07D 233/68
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16769761

PHOSPHATE-SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 455/02, A61P 31/18, A01N 43/90
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP12762253

N-PIPERIDIN-4-YL DERIVATIVES

IPC classification:
A61P 35/00, A61P 5/06, A61K 31/506, C07D 413/14, C07D 405/14, C07D 401/14, C07D 401/04
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Deeba Hussain, Merck & Co. Inc.
Status:
Request for examination was made
EP16800524

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL FOR TREATING HIV INFECTION

IPC classification:
A61K 31/53, A61K 31/4188, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16724066

NUCLEOTIDES FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/7068, C07H 19/11, C07H 19/10
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16818503

PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

IPC classification:
C07D 473/34, A61K 31/505, A61K 31/397
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16821846

PHARMACEUTICAL COMPOUND

IPC classification:
A61K 31/422, C07D 403/06, A61K 31/496
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16754372

CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS

IPC classification:
A61P 35/00, A61K 31/7084, C07H 21/00
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made
EP16835872

CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS

IPC classification:
C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
Deeba Hussain, Merck Sharp & Dohme Ltd.
Status:
Request for examination was made

Please Sign in to use this feature